International Longevity Day will see scientists, advocates and citizens carry the geroscience debate from medicine to Madrid City Hall.

PURR-001 increased body mass and muscle thickness in a small placebo-controlled feline study as TCHC signs its first European licensing deal.

Insilico’s new program combines AI, circular mRNA and in vivo T-cell engineering to target early cellular drivers of age-related disease.

AliveCor’s new KardiaACCESS program offers Medicare beneficiaries free, clinician-guided cardio-kidney-metabolic care.

There was a ribbon, a crowd, the usual photo line-up of executives and officials. However, the more interesting detail from ...

The company has launched The Elysium Longevity Institute, a physician-led clinical program meant to bring rigor to a field ...

Twelve candidate aging rate indicators could offer faster route to testing geroprotective drugs – and to understanding what ...

Durham University spinout Magnitude Biosciences raises $1.3 million to scale a platform that screens drugs in living worms, ...

Yale-led analysis harmonized 51 studies under one standardized pipeline, and senolytics came out looking shaky.

Company bets that AI-assisted analysis and a leaner trial design can get PrimeC to patients years sooner than the usual ...

AI model that reads heart scans becomes the first of its kind authorized by the FDA to catch heart attacks that standard ...

Cara Cassino spent a year advising Oligomerix from the boardroom. Now she’s running the company as its lead drug enters human ...